IRWD
Ironwood Pharmaceuticals IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$755.58M
P/E Ratio
28.69
EPS
$0.16
Beta
0.30
52W High
$5.78
52W Low
$0.53
50-Day MA
$3.69
200-Day MA
$2.83
Dividend Yield
—
Profit Margin
8.11%
Forward P/E
12.33
PEG Ratio
-0.26
About Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. The company is headquartered in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | $296.15M |
| Gross Profit (TTM) | $201.01M |
| EBITDA | $120.64M |
| Operating Margin | 13.70% |
| Return on Equity | -575.00% |
| Return on Assets | 19.90% |
| Revenue/Share (TTM) | $1.83 |
| Book Value | $-1.61 |
| Price-to-Book | 2.27 |
| Price-to-Sales (TTM) | 2.55 |
| EV/Revenue | 3.753 |
| EV/EBITDA | 10.62 |
| Quarterly Earnings Growth (YoY) | 1047.00% |
| Quarterly Revenue Growth (YoY) | -47.30% |
| Shares Outstanding | $164.61M |
| Float | $125.58M |
| % Insiders | 2.93% |
| % Institutions | 90.66% |
Historical Volatility
HV 10-Day
87.36%
HV 20-Day
74.97%
HV 30-Day
86.60%
HV 60-Day
87.65%
HV Rank
12.3%
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 5/5/2026